kdmf semaglutide registration FDA approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Semaglutide - Uses, DMF, Dossier,

Discontinuation rates: Semaglutide has a meaningfully better tolerability profile

Front Endocrinol 9:410

Reduce or discontinue use if you experience any adverse reactions, such as gastrointestinal irritation

Vitamin B12 deficiency can manifest in the following clinical conditions: - hyperchromic macrocytic megaloblastic anaemia (pernicious anaemia, Biermer's anaemia, Addison's anaemia), - funicular spinal disease

Aquat Toxicol 101(1):221227 Liu H, Guo Z, Xu L, Hsu S (2008) Protective effect of green tea polyphenols on tributyltin-induced oxidative damage detected by in vivo and in vitro models

12:39-50 [PMC free article: PMC7615591] [PubMed: 38061371] 193